Annual Report 2015–2016

Recommendations

Info

Eve, Year 3/4
4 Part PEOPLE MANAGEMENT People 110 Annual Report of the National Health and Medical Research Council 2015–2016 109
Page 1 and 2:
National Health and Medical Researc
Page 3 and 4:
A HEALTHY START TO LIFE NHMRC is co
Page 5 and 6:
CONTENTS ABOUT THE REPORT V PART 1
Page 7 and 8:
ABOUT THE REPORT This report was pr
Page 9 and 10:
PART1 OVERVIEW Chief Executive Offi
Page 11 and 12:
Structural review of NHMRC’s gran
Page 13 and 14:
During the year the NHMRC Council e
Page 15 and 16:
NHMRC’s strategy for health and m
Page 17 and 18:
RESEARCH FUNDING EXPENDITURE Fundin
Page 19 and 20:
PROMOTING EXCELLENCE THROUGH THE NH
Page 21 and 22:
Award Recipient Institution Researc
Page 23 and 24:
Award Recipient Institution Researc
Page 25 and 26:
CASE STUDY “This research is desi
Page 27 and 28:
ASSOCIATE PROFESSOR LEAH COSGROVE C
Page 29 and 30:
PROFESSOR LOUISA JORM WESTERN SYDNE
Page 31 and 32:
PART 2 PERFORMANCE REPORT Chief Exe
Page 33 and 34:
OUTCOMES AND PROGRAM STRUCTURE Thro
Page 35 and 36:
INVESTMENT Goal 5: Participate in d
Page 37 and 38:
TRANSLATION Goal 3: Develop public
Page 39 and 40:
INVESTMENT Create knowledge and bui
Page 41 and 42:
Table 3 Expenditure for Aboriginal
Page 43 and 44:
Figure 6 Expenditure by Science and
Page 45 and 46:
Targeted Calls for Research The out
Page 47 and 48:
GOAL 2: SUPPORT THE HEALTH AND MEDI
Page 49 and 50:
Table 11 People support outcomes fo
Page 51 and 52:
GOAL 3: BOOST DEMENTIA RESEARCH Boo
Page 53 and 54:
GOAL 4: SUPPORT COLLABORATIVE, MULT
Page 55 and 56:
Target 4: Finalise collaborative re
Page 57 and 58:
GOAL 6: SUPPORT RESEARCH THAT WILL
Page 59 and 60:
GOAL 7: PROMOTE ACCESS TO AND USE O
Page 61 and 62:
GOAL 8: IMPROVE THE GRANT APPLICATI
Page 63 and 64:
TRANSLATION Support the translation
Page 65 and 66: NHMRC also established a separate a
Page 67 and 68: GOAL 2: SUPPORT THE TRANSLATION OF
Page 69 and 70: Target 6: Publish an updated Statem
Page 71 and 72: In early 2016, the NHMRC completed
Page 73 and 74: GOAL 3: DEVELOP PUBLIC AND ENVIRONM
Page 75 and 76: Public consultation will be underta
Page 77 and 78: GOAL 4: REMOVE BARRIERS TO COMMERCI
Page 79 and 80: Table 17 NHMRC commitments to resea
Page 81 and 82: Target 2: Improve processes for cli
Page 83 and 84: GOAL 1: RETAIN HIGH ETHICAL STANDAR
Page 85 and 86: GOAL 2: STRENGTHEN THE PROCESS FOR
Page 87 and 88: Outcome 2: Strengthen the process f
Page 89 and 90: Target 3: Review Ethical Guidelines
Page 91 and 92: GOAL 4: ADMINISTER THE RESEARCH INV
Page 93 and 94: PART 3 OPERATING ENVIRONMENT Legisl
Page 95 and 96: CORPORATE GOVERNANCE Governance bod
Page 97 and 98: • the Chief Medical Officer or th
Page 99 and 100: The ERLC assesses applications for
Page 101 and 102: EXTERNAL SCRUTINY JUDICIAL DECISION
Page 103 and 104: In accordance with the RMF: • the
Page 105 and 106: Table 19 Freedom of Information req
Page 107 and 108: ACCOUNTABILITY PURCHASING AND PROCU
Page 109 and 110: Table 21 Consultancy services let d
Page 111 and 112: Complaints and their outcomes Of th
Page 113 and 114: CORRECTION OF MATERIAL ERRORS IN PR
Page 115: CASE STUDY The team studied diaphra
Page 119 and 120: Table 24 NHMRC employee overview as
Page 121 and 122: Consultations also raised the impor
Page 123 and 124: LEARNING AND DEVELOPMENT NHMRC’s
Page 125 and 126: Flexible workplace practices CASE S
Page 127 and 128: PART 5 FINANCIAL REPORT Financial P
Page 129 and 130: AGENCY RESOURCE STATEMENT Table 28
Page 131 and 132: INDEPENDENT AUDITOR’S REPORT To t
Page 133 and 134: PART 5 financial report Annual Repo
Page 135 and 136: Statement of Financial Position as
Page 137 and 138: Cash Flow Statement for the period
Page 139 and 140: Administered Reconciliation Schedul
Page 141 and 142: All new standards, amendments to st
Page 143 and 144: Reporting of Administered Activitie
Page 145 and 146: Income and Expenses Administered on
Page 147 and 148: Note 3.2 Non-Financial Assets Note
Page 149 and 150: Revaluations of non-financial asset
Page 151 and 152: Note 3.3 Other Payables 2016 2015 $
Page 153 and 154: Funding Note 5.1 Appropriations Not
Page 155 and 156: Note 5.3 Cash Flow Reconciliation R
Page 157 and 158: People and Relationships Note 6.1 P
Page 159 and 160: Managing Uncertainties Note 7.1 Con
Page 161 and 162: Note 7.2 Financial Instruments - Co
Page 163 and 164: Note 7.3 Administered - Financial I
Page 165 and 166: Other Information Note 8: Reporting
Page 167 and 168:
6 PART APPENDICES Appendix 1: Execu
Page 169 and 170:
Executive Director, Evidence, Advic
Page 171 and 172:
CHAIR OF NHMRC COUNCIL Chair Profes
Page 173 and 174:
Australian Capital Territory Dr Pau
Page 175 and 176:
Professor Michael Kidd AM Member wi
Page 177 and 178:
APPENDIX 3: RESEARCH COMMITTEE The
Page 179 and 180:
APPENDIX 5: EMBRYO RESEARCH LICENSI
Page 181 and 182:
APPENDIX 7: HEALTH INNOVATION ADVIS
Page 183 and 184:
APPENDIX 9: PUBLIC CONSULTATIONS Pu
Page 185 and 186:
IREG IRIISS JPco-fuND JPND MREA NAB
Page 187 and 188:
PGPA Rule Reference Part of Report
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
INDEX A Aboriginal and Torres Strai
Page 195 and 196:
Cancer 5, 66 National Evidence Base
Page 197:
S scholarships, 10, 39-41, 42 scien
show all

Annual Report 2015–2016

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?